Archive for July, 2016

July 28, 2016

San Diego, CA — Tamir Biotechnology, a leading developer of antiviral therapies, announced today the publication in the peer reviewed journal Antiviral Research, of ranpirnase activity against the Ebola virus. In this study involving both laboratory (in-vitro) and an established animal (in-vivo) model of Ebola infection, the authors confirmed the ability of ranpirnase to inhibit viral replication of Ebola, reduce virus levels of Ebola of infected mice and significantly extend survival times of animals treated with ranpirnase compared to a control animal group.


Continue reading
Back to top